<DOC>
	<DOCNO>NCT01232985</DOCNO>
	<brief_summary>The purpose study find investigational device , RD047-26 , safe useful treatment mild moderate atopic dermatitis .</brief_summary>
	<brief_title>Efficacy Tolerability Study Device , RD047-26 Treatment Mild Moderate Atopic Dermatitis Adults</brief_title>
	<detailed_description>RD047-26 , device , may tolerable effective treatment mild moderate atopic dermatitis associate pruritus adult . The treatment effect evaluate subject investigator .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<criteria>Written inform consent Female male , 18 65 year age good general health Clinical diagnosis stable mild moderate atopic dermatitis Willing able follow study instruction likely complete study requirement Severe uncontrolled asthma Pregnant , nursing , plan pregnancy study ; WOCBP willing use effective method birth control Current enrollment investigational drug device study participation study within last 30 day prior Baseline ( Day 0 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>Pruritus</keyword>
</DOC>